Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Structural and mechanistic characterization of an archaeal-like chaperonin from a thermophilic bacterium.

An YJ, Rowland SE, Na JH, Spigolon D, Hong SK, Yoon YJ, Lee JH, Robb FT, Cha SS.

Nat Commun. 2017 Oct 10;8(1):827. doi: 10.1038/s41467-017-00980-z.

2.

Purification, crystallization, and preliminary X-ray crystallographic analysis of the Group III chaperonin from Carboxydothermus hydrogenoformans.

An YJ, Rowland SE, Robb FT, Cha SS.

J Microbiol. 2016 Jun;54(6):440-4. doi: 10.1007/s12275-016-6089-5. Epub 2016 May 27.

PMID:
27225461
3.

An ecological process model of female sex offending: the role of victimization, psychological distress, and life stressors.

DeCou CR, Cole TT, Rowland SE, Kaplan SP, Lynch SM.

Sex Abuse. 2015 Jun;27(3):302-23. doi: 10.1177/1079063214556359. Epub 2014 Nov 20.

PMID:
25413945
4.

Self-determination and substance use: is effortful control a mediator?

Wong MM, Rowland SE.

Alcohol Clin Exp Res. 2013 Jun;37(6):1040-7. doi: 10.1111/acer.12062. Epub 2013 Feb 19.

PMID:
23421347
5.

Identification and characterization of a multidomain hyperthermophilic cellulase from an archaeal enrichment.

Graham JE, Clark ME, Nadler DC, Huffer S, Chokhawala HA, Rowland SE, Blanch HW, Clark DS, Robb FT.

Nat Commun. 2011 Jul 5;2:375. doi: 10.1038/ncomms1373.

PMID:
21730956
6.

Development of a homogeneous immunoassay for the detection of angiotensin I in plasma using AlphaLISA acceptor beads technology.

Cauchon E, Liu S, Percival MD, Rowland SE, Xu D, Binkert C, Strickner P, Falgueyret JP.

Anal Biochem. 2009 May 1;388(1):134-9. doi: 10.1016/j.ab.2009.02.031. Epub 2009 Mar 1.

PMID:
19258005
7.

MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.

Xu D, Rowland SE, Clark P, Giroux A, Côté B, Guiral S, Salem M, Ducharme Y, Friesen RW, Méthot N, Mancini J, Audoly L, Riendeau D.

J Pharmacol Exp Ther. 2008 Sep;326(3):754-63. doi: 10.1124/jpet.108.138776. Epub 2008 Jun 4.

PMID:
18524979
8.

MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.

Clark P, Rowland SE, Denis D, Mathieu MC, Stocco R, Poirier H, Burch J, Han Y, Audoly L, Therien AG, Xu D.

J Pharmacol Exp Ther. 2008 May;325(2):425-34. doi: 10.1124/jpet.107.134510. Epub 2008 Feb 20.

PMID:
18287210
9.

Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species.

Rowland SE, Clark P, Gordon R, Mullen AK, Guay J, Dufresne L, Brideau C, Cote B, Ducharme Y, Mancini J, Chan CC, Audoly L, Xu D.

Eur J Pharmacol. 2007 Apr 10;560(2-3):216-24. Epub 2007 Jan 20.

PMID:
17316604
10.

Palliative vs direct action stress-reduction procedures as treatments for reading disability.

Sharpley CF, Rowland SE.

Br J Educ Psychol. 1986 Feb;56 ( Pt 1):40-50. No abstract available.

PMID:
3513814

Supplemental Content

Loading ...
Support Center